Literature DB >> 21592318

Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines.

Solange Landreville1, François Vigneault, Marjorie-Allison Bergeron, Steeve Leclerc, Manon Gaudreault, Mohib Morcos, Frédéric Mouriaux, Christian Salesse, Sylvain L Guérin.   

Abstract

Cancer aggressiveness is related to the ability of cancer cells to escape the anchorage dependency toward the extracellular matrix, a process regulated by the integrin α5β1 and its ligand fibronectin. Here, we characterized the expression of the α5 gene in human uveal melanoma cell lines with distinct tumorigenic properties and investigated some of the mechanisms underlying the variations of their malignancy. Strong and weak expression of α5 was observed in cells with no (T108/T115) and high (T97/T98) tumorigenic properties, respectively. Expression and DNA binding of the transcription factors Sp1, activator protein 1 (AP-1) (both acting as activators), and nuclear factor I (NFI) (a strong repressor) to the α5 promoter were demonstrated in all cell lines. A reduced expression of AP-1 combined with a dramatic increase in NFI correlated with the suppression of α5 expression in T97 and T98 cells. Restoring α5 expression in T97 cells entirely abolished their tumorigenicity in immunodeficient mice. These uveal melanoma cell lines might therefore prove particularly useful as cellular models to investigate α5β1 function in the pathogenesis of invasive uveal melanoma.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592318     DOI: 10.1111/j.1755-148X.2011.00869.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  8 in total

1.  Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.

Authors:  Cindy Weidmann; Julie Bérubé; Léo Piquet; Arnaud de la Fouchardière; Solange Landreville
Journal:  Clin Exp Metastasis       Date:  2018-04-25       Impact factor: 5.150

2.  Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.

Authors:  I Tsaur; J Makarević; E Juengel; M Gasser; A-M Waaga-Gasser; M Kurosch; M Reiter; S Wedel; G Bartsch; A Haferkamp; C Wiesner; R A Blaheta
Journal:  Br J Cancer       Date:  2012-07-10       Impact factor: 7.640

3.  Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization.

Authors:  Solange Landreville; Caroline B Lupien; Francois Vigneault; Manon Gaudreault; Mélissa Mathieu; Alain P Rousseau; Sylvain L Guérin; Christian Salesse
Journal:  Mol Vis       Date:  2011-05-13       Impact factor: 2.367

4.  Repression of genes involved in melanocyte differentiation in uveal melanoma.

Authors:  Marjorie-Allison Bergeron; Sophie Champagne; Manon Gaudreault; Alexandre Deschambeault; Solange Landreville
Journal:  Mol Vis       Date:  2012-07-04       Impact factor: 2.367

5.  Differential responses of choroidal melanocytes and uveal melanoma cells to low oxygen conditions.

Authors:  Cindy Weidmann; Jade Pomerleau; Laurence Trudel-Vandal; Solange Landreville
Journal:  Mol Vis       Date:  2017-03-12       Impact factor: 2.367

6.  Contribution of the Transcription Factors Sp1/Sp3 and AP-1 to Clusterin Gene Expression during Corneal Wound Healing of Tissue-Engineered Human Corneas.

Authors:  Christelle Gross; Gaëtan Le-Bel; Pascale Desjardins; Manel Benhassine; Lucie Germain; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

7.  Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.

Authors:  Florence Schaffner; Anne Marie Ray; Monique Dontenwill
Journal:  Cancers (Basel)       Date:  2013-01-15       Impact factor: 6.639

8.  Transcription of the Human 5-Hydroxytryptamine Receptor 2B (HTR2B) Gene Is under the Regulatory Influence of the Transcription Factors NFI and RUNX1 in Human Uveal Melanoma.

Authors:  Manel Benhassine; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2018-10-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.